{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T13:37:32Z","timestamp":1789825052620,"version":"4.0.1"},"reference-count":156,"publisher":"Baishideng Publishing Group Inc.","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2016]]},"DOI":"10.3748\/wjg.v22.i1.262","type":"journal-article","created":{"date-parts":[[2015,12,31]],"date-time":"2015-12-31T06:06:16Z","timestamp":1451541976000},"page":"262","source":"Crossref","is-referenced-by-count":110,"title":["Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma"],"prefix":"10.3748","volume":"22","author":[{"given":"Pei-Pei","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","reference":[{"key":"ref1","unstructured":"World Health Organization. GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012. Accessed March 2, 2015. Available from: <ext-link ext-link-type=\"uri\" xlink:href=\"http:\/\/globocan.iarc.fr\/Pages\/fact_sheets_cancer.aspx\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\">http:\/\/globocan.iarc.fr\/Pages\/fact_sheets_cancer.aspx<\/ext-link>."},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Fattovich G, Stroffolini T, Zagni I, Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 2004;127:S35-S50.","DOI":"10.1053\/j.gastro.2004.09.014"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.","DOI":"10.3322\/canjclin.55.2.74"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2008.10.001"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2011.02.023"},{"key":"ref6","unstructured":"Hepatitis B vaccines. Wkly Epidemiol Rec 2009;84:405-419."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.12.116"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyi206"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v7.i3.616"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Zhang C, Zhong Y, Guo L. Strategies to prevent hepatitis B virus infection in China: immunization, screening, and standard medical practices. Biosci Trends 2013;7:7-12.","DOI":"10.5582\/bst.2013.v7.1.7"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Alter MJ. The epidemiology of acute and chronic hepatitis C. Clin Liver Dis 1997;1:559-68, vi-vii.","DOI":"10.1016\/S1089-3261(05)70321-4"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Ryder SD, Irving WL, Jones DA, Neal KR, Underwood JC. Progression of hepatic fibrosis in patients with hepatitis C: a prospective repeat liver biopsy study. Gut 2004;53:451-455.","DOI":"10.1136\/gut.2003.021691"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2002.36806"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000000341"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2007.04883.x"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s00430-014-0369-7"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2012.02792.x"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2014.07.018"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24199"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2011.12.001"},{"key":"ref21","unstructured":"Benson AB, D&rsquo;Angelica MI, Abrams TA, Are C, Bloomston PM, Chang DT, Clary BM, Covey AM, Ensminger WD, Iyer R. Hepatobiliary cancers, version 2.2014. J Natl Compr Canc Netw 2014;12:1152-1182."},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-010-9165-7"},{"key":"ref23","unstructured":"NHaFP Commission. The Guideline on Diagnosis and Treatment for Primary Liver Cancer (2011 version, in Chinese). Accessed 16 March, 2015. Available from: <ext-link ext-link-type=\"uri\" xlink:href=\"http:\/\/www.moh.gov.cn\/mohyzs\/s3586\/201110\/53153.shtml\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\">http:\/\/www.moh.gov.cn\/mohyzs\/s3586\/201110\/53153.shtml<\/ext-link>."},{"key":"ref24","unstructured":"Clinical practice guidelines for hepatocellular carcinoma (2013 version) Kanehara, Tokyo, Japan: Hepatology. JSo; ."},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20933"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Benson AB, Abrams TA, Ben-Josef E, Bloomston PM, Botha JF, Clary BM, Covey A, Curley SA, D&rsquo;Angelica MI, Davila R. NCCN clinical practice guidelines in oncology: hepatobiliary cancers. J Natl Compr Canc Netw 2009;7:350-391.","DOI":"10.6004\/jnccn.2009.0027"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26141"},{"key":"ref28","unstructured":"Pan CQ, Zhang JX. Natural History and Clinical Consequences of Hepatitis B Virus Infection. Int J Med Sci 2005;2:36-40."},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21627"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra031087"},{"key":"ref31","unstructured":"Guo F, Gao Y, Wang QX, Sun DG, Ji Y, Cong X, Sun Y, Wang H, Wei L. [Clinical outcomes of women with transfusion-associated hepatitis C after 10-15 years follow-up]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 2004;18:132-136."},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22375"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.04.061"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2011.10.009"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.08.048"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00694-12"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.02.055"},{"key":"ref38","unstructured":"World Health Organization. Guidelines for the Prevention, Care and Treatment of Persons with Chronic Hepatitis B Infection. Accessed April 5, 2015. Available from: <ext-link ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/hiv\/pub\/hepatitis\/hepatitis-b-guidelines\/en\/\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\">http:\/\/www.who.int\/hiv\/pub\/hepatitis\/hepatitis-b-guidelines\/en\/<\/ext-link>."},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23190"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22759"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-012-9386-z"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-012-9342-y"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.02.010"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.11.003"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.05.016"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"Myers RP, Ramji A, Bilodeau M, Wong S, Feld JJ. An update on the management of hepatitis C: consensus guidelines from the Canadian Association for the Study of the Liver. Can J Gastroenterol 2012;26:359-375.","DOI":"10.1155\/2012\/947676"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0b013e318258328d"},{"key":"ref48","unstructured":"World Health Organization. Guidelines for the Screening, Care and Treatment of Persons with Hepatitis C Infection. Accessed April 5, 2015. Available from: <ext-link ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/hiv\/pub\/hepatitis\/hepatitis-c-guidelines\/en\/\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\">http:\/\/www.who.int\/hiv\/pub\/hepatitis\/hepatitis-c-guidelines\/en\/<\/ext-link>."},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1111\/j.1872-034X.2010.00650.x"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2011.03.027"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2007.09.020"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-010-1366-3"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001624"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2014.03.050"},{"key":"ref55","doi-asserted-by":"crossref","unstructured":"Song P, Feng X, Zhang K, Song T, Ma K, Kokudo N, Dong J, Yao L, Tang W. Screening for and surveillance of high-risk patients with HBV-related chronic liver disease: promoting the early detection of hepatocellular carcinoma in China. Biosci Trends 2013;7:1-6.","DOI":"10.5582\/bst.2013.v7.1.1"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-014-2806-6"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000000012"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.02.090"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2015.100"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2010.06419.x"},{"key":"ref61","doi-asserted-by":"crossref","unstructured":"Chrysanthos NV, Papatheodoridis GV, Savvas S, Kafiri G, Petraki K, Manesis EK, Archimandritis AJ. Aspartate aminotransferase to platelet ratio index for fibrosis evaluation in chronic viral hepatitis. Eur J Gastroenterol Hepatol 2006;18:389-396.","DOI":"10.1097\/00042737-200604000-00012"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2010.05.035"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2000.17914"},{"key":"ref64","unstructured":"Sherman M, Peltekian KM, Lee C. Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a North American urban population. Hepatology 1995;22:432-438."},{"key":"ref65","doi-asserted-by":"crossref","unstructured":"Lok AS, Lai CL. alpha-Fetoprotein monitoring in Chinese patients with chronic hepatitis B virus infection: role in the early detection of hepatocellular carcinoma. Hepatology 1989;9:110-115.","DOI":"10.1002\/hep.1840090119"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2012.11.029"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-11-1005"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2009.11.026"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2009.04014.x"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.10.031"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1159\/000111717"},{"key":"ref72","unstructured":"Barletta E, Tinessa V, Daniele B. Screening of hepatocellular carcinoma: role of the alpha-fetoprotein (AFP) and ultrasonography. Recenti Prog Med 2005;96:295-299; quiz 328."},{"key":"ref73","doi-asserted-by":"crossref","unstructured":"Daniele B, Bencivenga A, Megna AS, Tinessa V. Alpha-fetoprotein and ultrasonography screening for hepatocellular carcinoma. Gastroenterology 2004;127:S108-S112.","DOI":"10.1053\/j.gastro.2004.09.023"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2004.12.006"},{"key":"ref75","doi-asserted-by":"crossref","unstructured":"Di Bisceglie AM, Hoofnagle JH. Elevations in serum alpha-fetoprotein levels in patients with chronic hepatitis B. Cancer 1989;64:2117-2120.","DOI":"10.1002\/1097-0142(19891115)64:10<2117::AID-CNCR2820641024>3.0.CO;2-7"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-009-0547-y"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-007-9038-x"},{"key":"ref78","doi-asserted-by":"crossref","unstructured":"Bolondi L. Screening for hepatocellular carcinoma in cirrhosis. J Hepatol 2003;39:1076-1084.","DOI":"10.1016\/S0168-8278(03)00349-0"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-004-0552-0"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24033"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-013-0883-1"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.04.005"},{"key":"ref83","doi-asserted-by":"crossref","unstructured":"Shimauchi Y, Tanaka M, Kuromatsu R, Ogata R, Tateishi Y, Itano S, Ono N, Yutani S, Nagamatsu H, Matsugaki S. A simultaneous monitoring of Lens culinaris agglutinin A-reactive alpha-fetoprotein and des-gamma-carboxy prothrombin as an early diagnosis of hepatocellular carcinoma in the follow-up of cirrhotic patients. Oncol Rep 2000;7:249-256.","DOI":"10.3892\/or.7.2.249"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2008.05395.x"},{"key":"ref85","doi-asserted-by":"crossref","unstructured":"Kasahara A, Hayashi N, Fusamoto H, Kawada Y, Imai Y, Yamamoto H, Hayashi E, Ogihara T, Kamada T. Clinical evaluation of plasma des-gamma-carboxy prothrombin as a marker protein of hepatocellular carcinoma in patients with tumors of various sizes. Dig Dis Sci 1993;38:2170-2176.","DOI":"10.1007\/BF01299891"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1999.00930.x"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2010.214916"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2005.05.028"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdm448"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2006.10.036"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2007.05.014"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2013-306627"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1159\/000327577"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2007.04.001"},{"key":"ref95","unstructured":"Kew MC. Alpha-fetoprotein. London: Butterworths; 1975;91."},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.1111\/hpb.12146"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1080\/13651820410024049"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2012.18.3.258"},{"key":"ref99","doi-asserted-by":"crossref","unstructured":"Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, Christensen E, Pagliaro L, Colombo M, Rod&eacute;s J. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001;35:421-430.","DOI":"10.1016\/S0168-8278(01)00130-1"},{"key":"ref100","unstructured":"Park JW. Practice guideline for diagnosis and treatment of hepatocellular carcinoma. Korean J Hepatol 2004;10:88-98."},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.3350\/kjhep.2009.15.3.391"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199306243282502"},{"key":"ref103","unstructured":"Taketa K, Endo Y, Sekiya C, Tanikawa K, Koji T, Taga H, Satomura S, Matsuura S, Kawai T, Hirai H. A collaborative study for the evaluation of lectin-reactive alpha-fetoproteins in early detection of hepatocellular carcinoma. Cancer Res 1993;53:5419-5423."},{"key":"ref104","doi-asserted-by":"crossref","unstructured":"Gao J, Feng X, Inagaki Y, Song P, Kokudo N, Hasegawa K, Sugawara Y, Tang W. Des-&gamma;-carboxy prothrombin and c-Met were concurrently and extensively expressed in hepatocellular carcinoma and associated with tumor recurrence. Biosci Trends 2012;6:153-159.","DOI":"10.5582\/bst.2012.v6.4.153"},{"key":"ref105","doi-asserted-by":"publisher","DOI":"10.3390\/ijms141223559"},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.3892\/or.2012.2147"},{"key":"ref107","doi-asserted-by":"publisher","DOI":"10.3978\/j.issn.2304-3881.2013.08.11"},{"key":"ref108","doi-asserted-by":"crossref","unstructured":"Song P, Tang W, Hasegawa K, Kokudo N. Systematic evidence-based clinical practice guidelines are ushering in a new stage of standardized management of hepatocellular carcinoma in Japan. Drug Discov Ther 2014;8:64-70.","DOI":"10.5582\/ddt.8.64"},{"key":"ref109","doi-asserted-by":"crossref","unstructured":"Zhang K, Song P, Gao J, Li G, Zhao X, Zhang S. Perspectives on a combined test of multi serum biomarkers in China: towards screening for and diagnosing hepatocellular carcinoma at an earlier stage. Drug Discov Ther 2014;8:102-109.","DOI":"10.5582\/ddt.2014.01026"},{"key":"ref110","doi-asserted-by":"crossref","unstructured":"Song P, Feng X, Inagaki Y, Song T, Zhang K, Wang Z, Zheng S, Ma K, Li Q, Kong D. Clinical utility of simultaneous measurement of alpha-fetoprotein and des-&gamma;-carboxy prothrombin for diagnosis of patients with hepatocellular carcinoma in China: A multi-center case-controlled study of 1,153 subjects. Biosci Trends 2014;8:266-273.","DOI":"10.5582\/bst.2014.01116"},{"key":"ref111","doi-asserted-by":"crossref","unstructured":"Song P. Standardizing management of hepatocellular carcinoma in China: devising evidence-based clinical practice guidelines. Biosci Trends 2013;7:250-252.","DOI":"10.5582\/bst.2013.v7.5.250"},{"key":"ref112","doi-asserted-by":"publisher","DOI":"10.5582\/bst.2012.v6.3.147"},{"key":"ref113","doi-asserted-by":"crossref","unstructured":"Capurro M, Wanless IR, Sherman M, Deboer G, Shi W, Miyoshi E, Filmus J. Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma. Gastroenterology 2003;125:89-97.","DOI":"10.1016\/S0016-5085(03)00689-9"},{"key":"ref114","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2009.05988.x"},{"key":"ref115","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.00679.x"},{"key":"ref116","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24703"},{"key":"ref117","unstructured":"Mukozu T, Nagai H, Matsui D, Kanekawa T, Sumino Y. Serum VEGF as a tumor marker in patients with HCV-related liver cirrhosis and hepatocellular carcinoma. Anticancer Res 2013;33:1013-1021."},{"key":"ref118","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(12)70233-4"},{"key":"ref119","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-3363"},{"key":"ref120","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21244"},{"key":"ref121","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-1001"},{"key":"ref122","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.38.2697"},{"key":"ref123","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2011.04.026"},{"key":"ref124","doi-asserted-by":"crossref","unstructured":"Tung-Ping Poon R, Fan ST, Wong J. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg 2000;232:10-24.","DOI":"10.1097\/00000658-200007000-00003"},{"key":"ref125","doi-asserted-by":"publisher","DOI":"10.1007\/s00423-010-0643-0"},{"key":"ref126","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2008.05340.x"},{"key":"ref127","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-2175"},{"key":"ref128","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2008.01957.x"},{"key":"ref129","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.2010.295"},{"key":"ref130","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.23.1282"},{"key":"ref131","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0b013e32835d913b"},{"key":"ref132","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.02.016"},{"key":"ref133","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2010.06532.x"},{"key":"ref134","doi-asserted-by":"publisher","DOI":"10.1111\/j.1872-034X.2012.01004.x"},{"key":"ref135","doi-asserted-by":"crossref","unstructured":"Fujiyama S, Tanaka M, Maeda S, Ashihara H, Hirata R, Tomita K. Tumor markers in early diagnosis, follow-up and management of patients with hepatocellular carcinoma. Oncology 2002;62 Suppl 1:57-63.","DOI":"10.1159\/000048277"},{"key":"ref136","doi-asserted-by":"crossref","unstructured":"Toyoda H, Kumada T, Kiriyama S, Sone Y, Tanikawa M, Hisanaga Y, Yamaguchi A, Isogai M, Kaneoka Y, Washizu J. Prognostic significance of simultaneous measurement of three tumor markers in patients with hepatocellular carcinoma. Clin Gastroenterol Hepatol 2006;4:111-117.","DOI":"10.1016\/S1542-3565(05)00855-4"},{"key":"ref137","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e3182215016"},{"key":"ref138","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.12277"},{"key":"ref139","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/310427"},{"key":"ref140","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0087011"},{"key":"ref141","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2014.04.003"},{"key":"ref142","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-014-0966-8"},{"key":"ref143","doi-asserted-by":"crossref","unstructured":"Cui X, Li Z, Gao PJ, Gao J, Zhu JY. Prognostic value of glypican-3 in patients with HBV-associated hepatocellular carcinoma after liver transplantation. Hepatobiliary Pancreat Dis Int 2015;14:157-163.","DOI":"10.1016\/S1499-3872(15)60349-6"},{"key":"ref144","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0072306"},{"key":"ref145","doi-asserted-by":"crossref","unstructured":"Wang Z, Song P, Xia J, Inagaki Y, Tang W, Kokudo N. Can gamma-glutamyl transferase levels contribute to a better prognosis for patients with hepatocellular carcinoma? Drug Discov Ther 2014;8:134-138.","DOI":"10.5582\/ddt.2014.01025"},{"key":"ref146","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v9.i3.468"},{"key":"ref147","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-009-0050-x"},{"key":"ref148","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2013.04.003"},{"key":"ref149","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v18.i25.3272"},{"key":"ref150","doi-asserted-by":"crossref","unstructured":"Carr BI, Pancoska P, Branch RA. Low alpha-fetoprotein hepatocellular carcinoma. J Gastroenterol Hepatol 2010;25:1543-1549.","DOI":"10.1111\/j.1440-1746.2010.06303.x"},{"key":"ref151","doi-asserted-by":"publisher","DOI":"10.1007\/s00270-011-0293-9"},{"key":"ref152","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2013.1578"},{"key":"ref153","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0b013e32834902dd"},{"key":"ref154","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2013.06.002"},{"key":"ref155","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22160"},{"key":"ref156","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v7.i2.139"}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v22\/i1\/262.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T02:54:05Z","timestamp":1567479245000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v22\/i1\/262.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":156,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.3748\/wjg.v22.i1.262","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}